Bhaskar Chaudhuri - 12 Jun 2025 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Reporting relationship: Director
Issuer ticker: ARQT
Reported as of: 12 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2025, 20:16:55 UTC
Prior SEC filing: 25 Jun 2024
Next SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Latha Vairavan, as Attorney-in-Fact for Bhaskar Chaudhuri

Key filing fact

Bhaskar Chaudhuri filed Form 4 for Arcutis Biotherapeutics, Inc. (ARQT) on 16 Jun 2025.

Key facts

This page summarizes Bhaskar Chaudhuri's Form 4 filing for Arcutis Biotherapeutics, Inc. (ARQT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2025, 20:16.

Change

Previous filing in this sequence was filed on 25 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001458643 Primary reporting owner

CHAUDHURI BHASKAR

Relationship: Director
Address: C/O ARCUTIS BIOTHERAPEUTICS, INC., 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE
Signature: /s/ Latha Vairavan, as Attorney-in-Fact for Bhaskar Chaudhuri
Signature date: 16 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARQT transaction

Common Stock

Award

Transaction value: $0
Shares: +7,609
Change %: +0.88%
Price: $0.000000
Shares after: 867,826
Date: 12 Jun 2025
Ownership: Direct
Footnotes: F1

ARQT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 49,981
Date: 12 Jun 2025
Ownership: By Trust
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARQT transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +20,568
Change %
Price: $0.000000
Shares after: 20,568
Date: 12 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,568
Exercise price: $13.50
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on December 11, 2024, maintained by the Company.

Footnote F2

The securities are held of record by The Chaudhuri Family Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Footnote F3

The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.

SEC remarks

Exhibit List: Exhibit 24.1 - Power of Attorney